SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-025651
Filing Date
2024-08-09
Accepted
2024-08-09 08:02:22
Documents
57
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr20240630_10q.htm   iXBRL 10-Q 922607
2 EXHIBIT 10.1 ex_705820.htm EX-10.1 65641
3 EXHIBIT 31.1 ex_678443.htm EX-31.1 13260
4 EXHIBIT 31.2 ex_678444.htm EX-31.2 13257
5 EXHIBIT 32.1 ex_678445.htm EX-32.1 8431
  Complete submission text file 0001437749-24-025651.txt   4659204

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240630.xsd EX-101.SCH 36373
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20240630_cal.xml EX-101.CAL 20555
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240630_def.xml EX-101.DEF 277332
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240630_lab.xml EX-101.LAB 238364
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240630_pre.xml EX-101.PRE 295386
60 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240630_10q_htm.xml XML 715333
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 241190456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)